NUR100/l NURl 100l Examl 1:l (Latestl
2025/l 2026l Update)l Pharmacologyl Guidel
|l Qsl andl As|l 100%l Correct|l Gradel Al
(Verifiedl Answers)–l Fortis
QUESTION
Agonist
Answer:
Drugl bindsl tol thel receptor;l therel isl al response.
QUESTION
Partiall Agonist
Answer:
Drugl bindsl tol thel receptor;l thel responsel isl diminishedl comparedl withl thatl elicitedl byl
anl agonist.
QUESTION
Antagonist
Answer:
Drugl bindsl tol receptor;l therel isl nol response,l drugl preventsl bindingl ofl agonists.
QUESTION
Competitivel Antagonist
Answer:
Drugl competesl withl thel agonistl forl bindingl tol thel receptor.l Ifl itl binds,l therel isl nol
response.
,QUESTION
Noncompetitivel Antagonist
Answer:
Drugl combinesl withl differentl partsl ofl thel receptorl andl inactivatesl it;l agonistl thenl hasl
nol effect.
QUESTION
Affinity
Answer:
Thel degreel tol whichl al drugl attachesl tol andl bindsl withl al receptor.
QUESTION
Pharmacotherapeutics
Answer:
Treatmentl ofl pathologicl conditionsl throughl thel usel ofl drugs.
QUESTION
Acutel Therapy
Answer:
Involvesl morel intensivel drugl treatmentsl andl isl implementedl inl thel acutelyl illl orl thel
criticallyl ill.
QUESTION
Maintenancel Therapy
Answer:
Doesl notl eradicatel preexistingl problems,l butl willl preventl progressionl ofl al diseasel orl
condition.
, QUESTION
Supplementall Therapy
Answer:
Suppliesl thel bodyl withl al substancel neededl tol maintainl normall function.
QUESTION
Palliativel Therapy
Answer:
Makel thel patientl asl comfortablel asl possible;l focusesl onl providingl patientsl withl reliefl
froml thel symptoms,l pain,l andl stressl ofl al seriousl illness.
QUESTION
Qualityl ofl Life
Answer:
Goall isl tol improvel qualityl ofl lifel forl bothl patientl andl family
QUESTION
Supportivel Therapy
Answer:
Maintainsl thel integrityl ofl bodyl functionsl whilel thel patientl isl recoveringl froml illnessl orl
trauma
QUESTION
Prophylacticl Therapy
Answer:
2025/l 2026l Update)l Pharmacologyl Guidel
|l Qsl andl As|l 100%l Correct|l Gradel Al
(Verifiedl Answers)–l Fortis
QUESTION
Agonist
Answer:
Drugl bindsl tol thel receptor;l therel isl al response.
QUESTION
Partiall Agonist
Answer:
Drugl bindsl tol thel receptor;l thel responsel isl diminishedl comparedl withl thatl elicitedl byl
anl agonist.
QUESTION
Antagonist
Answer:
Drugl bindsl tol receptor;l therel isl nol response,l drugl preventsl bindingl ofl agonists.
QUESTION
Competitivel Antagonist
Answer:
Drugl competesl withl thel agonistl forl bindingl tol thel receptor.l Ifl itl binds,l therel isl nol
response.
,QUESTION
Noncompetitivel Antagonist
Answer:
Drugl combinesl withl differentl partsl ofl thel receptorl andl inactivatesl it;l agonistl thenl hasl
nol effect.
QUESTION
Affinity
Answer:
Thel degreel tol whichl al drugl attachesl tol andl bindsl withl al receptor.
QUESTION
Pharmacotherapeutics
Answer:
Treatmentl ofl pathologicl conditionsl throughl thel usel ofl drugs.
QUESTION
Acutel Therapy
Answer:
Involvesl morel intensivel drugl treatmentsl andl isl implementedl inl thel acutelyl illl orl thel
criticallyl ill.
QUESTION
Maintenancel Therapy
Answer:
Doesl notl eradicatel preexistingl problems,l butl willl preventl progressionl ofl al diseasel orl
condition.
, QUESTION
Supplementall Therapy
Answer:
Suppliesl thel bodyl withl al substancel neededl tol maintainl normall function.
QUESTION
Palliativel Therapy
Answer:
Makel thel patientl asl comfortablel asl possible;l focusesl onl providingl patientsl withl reliefl
froml thel symptoms,l pain,l andl stressl ofl al seriousl illness.
QUESTION
Qualityl ofl Life
Answer:
Goall isl tol improvel qualityl ofl lifel forl bothl patientl andl family
QUESTION
Supportivel Therapy
Answer:
Maintainsl thel integrityl ofl bodyl functionsl whilel thel patientl isl recoveringl froml illnessl orl
trauma
QUESTION
Prophylacticl Therapy
Answer:
